CeNCs exhibited high ROS activity and antioxidant properties in mitochondrial oxidative-stress-induced damage therapy in Alzheimer’s disease, acting as tau hyperphosphorylation inhibitors. The gene discussed is MAPT; the disease is Alzheimer disease.